secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioScience Health Innovations, Inc. (BHIC)
CIK:        0001784440
Form:       8-K
Filed at:   2023-03-16T23:59:59+00:00
Accession:  0001185185-23-000223
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.80
Item codes: 2.01, 3.02, 5.02, 5.03, 5.06, 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Nowtransit completes reverse merger with Best Labs; new CEO and board appointed
-------------------------------------------------------------------------------

- Nowtransit issued 34,371,100 shares (85.39% of outstanding) for 100% of Best Labs common stock.
- Darren Lopez appointed CEO and director; John Chymboryk appointed director; Justin Earl resigned as officer.
- Fiscal year changed from August 31 to December 31 to align with Best Labs.
- Company ceased being a shell company upon closing of the share exchange.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1784440/000118518523000223/0001185185-23-000223-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1784440/000118518523000223/nowtransit20230316_8k.htm
  HTML page:      https://secwatch.observer/filing/0001185185-23-000223

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer